Bioingeniería aplicada a modelos conductuales en animales de experimentación

Promover el desarrollo de equipo y software para investigación biomédica, favorece la independencia tecnológica y económica del extranjero. Además, las investigaciones se enriquecen, los tratamientos a pacientes se vuelven factibles y disminuyen los costos. Con ello, favorecemos el desarrollo de herramientas biotecnológicas de calidad e incidimos en la apertura de fuentes de empleo. A continuación mostramos una breve recopilación bibliográfica respecto a la influencia del desarrollo biotecnológico sobre el estudio de conductas relacionadas con ansiedad, depresión, aprendizaje y adicción

Disfunción familiar y depresión en niños de 8-12 años de edad

La población estudiada incluyó 326 niños, de 8 a 12 años de edad. De ellos el 54.3% correspondió al género femenino y el 45.7% al masculino, predominando en frecuencia los niños en edades de 9 a 11 años.Introducción: La frecuencia de depresión infantil se ha incrementado en años recientes y constantemente se asocia a un ambiente familiar disfuncional. El objetivo fue determinar la correlación entre disfuncionalidad familiar y depresión infantil en niños de 8 a 12 años de edad. Materiales y métodos: En una muestra probabilística, aleatoria de 326 niños de 8 a 12 años de edad, de una escuela primaria semiurbana, de bajo nivel socioeconómico en el Estado de México, se determinó la frecuencia de depresión infantil, aplicándose la escala modificada Children’s Depression Inventory (CDI) de Kovacs, 2004 y Kovacs y Beck, 1977. Para evaluación de la funcionalidad familiar, se aplicó a padres de familia la escala reajuste social de Holmes. Resultados: Se identificó correlación estadísticamente significativa al nivel de 0.01 entre disfunción familiar y depresión infantil. El 34.1% de los familiares de los niños en estudio fueron disfuncionales, sólo el 11.7% de los sujetos manifestó síntomas de depresión infantil y de ellos únicamente el 8.7% se relacionó con disfuncionalidad familiar. Conclusiones: Se encontró correlación estadísticamente significativa entre disfunción familiar y depresión infantil, afectando en mayor porcentaje al género femenino y con mayor prevalencia en los niños de 8, 10 y 11años de eda

Características clínicas de la retinopatía diabética en pacientes enviados al Servicio de Oftalmología

Introducción: La retinopatía diabética (RD) es la tercera causa de ceguera de tipo irreversible en el mundo, pero prevenible. EL objetivo de esta investigación fue identificar sus características clínicas y el estadio en que Los pacientes son enviados al Servicio de Oftalmología, del Hospital General Regional (HGR) NC 220 del MSS. Objetivo: Determinar el estadio de RD de Los pacientes que son enviados por primera vez, al Servicio de Oftalmología del HGR N° 220 del IMSS Materiales y método: Se realizó un estudio prospectivo, descriptivo y transversal. A través de una cédula y la exploración oftalmológica realizada a los pacientes, se identificaron Ias características clínicas de 65 pacientes con diabetes mellitus tipo 2 (DM 2), de Los cuales 32 presentaron RD y 33 no la presentaron, por lo que fueron eliminados del estudio. Resultados: El estadio más frecuente fue el no proliferativo leve (40.62%), sin embargo se encontró un gran porcentaje de estadios avanzados. Por otra parte, La patología sistémica asociada más frecuente fue Ia hipertensión arterial. Conclusiones: El porcentaje de pacientes con estadios avanzados de RD, hace imprescindible reflexionar sobre el manejo del paciente con diabetes, siendo necesario un mayor control de la glicemia y una adecuada revisión oftalmológica

Variaciones climáticas en la Zona Metropolitana de la Ciudad de Toluca, Estado de México: 1960-2007

Los científicos del Panel Intergubernamental para el Cambio Climático (ipcc, 2001), han analizado las posibles consecuencias que pueden representar los cambios climáticos en distintos espacios geográficos de la Tierra. En México, el cambio climático empieza a ser notorio, por esta razón se realizó una investigación en la Zona Metropolitana de la Ciudad de Toluca y su hinterland para estudiar el comportamiento de la temperatura y la precipitación entre 1960 y 2007, y demostrar la existencia de variaciones que pueden contribuir al cambio climático. El sustento teórico de esta investigación fue la geografía ambiental, y el metodológico se basó en la estadística, trabajo de campo, el método comparativo y la cartografía automatizada. Con los resultados obtenidos se puede concluir que el clima en la zmct y su hinterland están en proceso de cambio y, de acuerdo con las investigaciones e informes de la nasa y el ipcc, éste seguirá cambiando globalmente.Los cientíÀcos del Panel Intergubernamental para el Cambio Climático (ipcc, 2001), han analizado las posibles consecuencias que pueden representar los cambios climáticos en distintos espacios geográÀcos de la Tierra. En México, el cambio climático empieza a ser notorio, por esta razón se realizó una investigación en la Zona Metropolitana de la Ciudad de Toluca y su hinterland para estudiar el comportamiento de la temperatura y la precipitación entre 1960 y 2007, y demostrar la existencia de variaciones que pueden contribuir al cambio climático. El sustento teórico de esta investigación fue la geografía ambiental, y el metodológico se basó en la estadística, trabajo de campo, el método comparativo y la cartografía automatizada. Con los resultados obtenidos se puede concluir que el clima en la zmct y su hinterland están en proceso de cambio y, de acuerdo con las investigaciones e informes de la nasa y el ipcc, éste seguirá cambiando globalmente

Global Retinoblastoma Presentation and Analysis by National Income Level.

Importance: Early diagnosis of retinoblastoma, the most common intraocular cancer, can save both a child's life and vision. However, anecdotal evidence suggests that many children across the world are diagnosed late. To our knowledge, the clinical presentation of retinoblastoma has never been assessed on a global scale. Objectives: To report the retinoblastoma stage at diagnosis in patients across the world during a single year, to investigate associations between clinical variables and national income level, and to investigate risk factors for advanced disease at diagnosis. Design, Setting, and Participants: A total of 278 retinoblastoma treatment centers were recruited from June 2017 through December 2018 to participate in a cross-sectional analysis of treatment-naive patients with retinoblastoma who were diagnosed in 2017. Main Outcomes and Measures: Age at presentation, proportion of familial history of retinoblastoma, and tumor stage and metastasis. Results: The cohort included 4351 new patients from 153 countries; the median age at diagnosis was 30.5 (interquartile range, 18.3-45.9) months, and 1976 patients (45.4%) were female. Most patients (n = 3685 [84.7%]) were from low- and middle-income countries (LMICs). Globally, the most common indication for referral was leukocoria (n = 2638 [62.8%]), followed by strabismus (n = 429 [10.2%]) and proptosis (n = 309 [7.4%]). Patients from high-income countries (HICs) were diagnosed at a median age of 14.1 months, with 656 of 666 (98.5%) patients having intraocular retinoblastoma and 2 (0.3%) having metastasis. Patients from low-income countries were diagnosed at a median age of 30.5 months, with 256 of 521 (49.1%) having extraocular retinoblastoma and 94 of 498 (18.9%) having metastasis. Lower national income level was associated with older presentation age, higher proportion of locally advanced disease and distant metastasis, and smaller proportion of familial history of retinoblastoma. Advanced disease at diagnosis was more common in LMICs even after adjusting for age (odds ratio for low-income countries vs upper-middle-income countries and HICs, 17.92 [95% CI, 12.94-24.80], and for lower-middle-income countries vs upper-middle-income countries and HICs, 5.74 [95% CI, 4.30-7.68]). Conclusions and Relevance: This study is estimated to have included more than half of all new retinoblastoma cases worldwide in 2017. Children from LMICs, where the main global retinoblastoma burden lies, presented at an older age with more advanced disease and demonstrated a smaller proportion of familial history of retinoblastoma, likely because many do not reach a childbearing age. Given that retinoblastoma is curable, these data are concerning and mandate intervention at national and international levels. Further studies are needed to investigate factors, other than age at presentation, that may be associated with advanced disease in LMICs

Cabbage and fermented vegetables : From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19

Large differences in COVID-19 death rates exist between countries and between regions of the same country. Some very low death rate countries such as Eastern Asia, Central Europe, or the Balkans have a common feature of eating large quantities of fermented foods. Although biases exist when examining ecological studies, fermented vegetables or cabbage have been associated with low death rates in European countries. SARS-CoV-2 binds to its receptor, the angiotensin-converting enzyme 2 (ACE2). As a result of SARS-CoV-2 binding, ACE2 downregulation enhances the angiotensin II receptor type 1 (AT(1)R) axis associated with oxidative stress. This leads to insulin resistance as well as lung and endothelial damage, two severe outcomes of COVID-19. The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is the most potent antioxidant in humans and can block in particular the AT(1)R axis. Cabbage contains precursors of sulforaphane, the most active natural activator of Nrf2. Fermented vegetables contain many lactobacilli, which are also potent Nrf2 activators. Three examples are: kimchi in Korea, westernized foods, and the slum paradox. It is proposed that fermented cabbage is a proof-of-concept of dietary manipulations that may enhance Nrf2-associated antioxidant effects, helpful in mitigating COVID-19 severity.Peer reviewe

Nrf2-interacting nutrients and COVID-19 : time for research to develop adaptation strategies

There are large between- and within-country variations in COVID-19 death rates. Some very low death rate settings such as Eastern Asia, Central Europe, the Balkans and Africa have a common feature of eating large quantities of fermented foods whose intake is associated with the activation of the Nrf2 (Nuclear factor (erythroid-derived 2)-like 2) anti-oxidant transcription factor. There are many Nrf2-interacting nutrients (berberine, curcumin, epigallocatechin gallate, genistein, quercetin, resveratrol, sulforaphane) that all act similarly to reduce insulin resistance, endothelial damage, lung injury and cytokine storm. They also act on the same mechanisms (mTOR: Mammalian target of rapamycin, PPAR gamma:Peroxisome proliferator-activated receptor, NF kappa B: Nuclear factor kappa B, ERK: Extracellular signal-regulated kinases and eIF2 alpha:Elongation initiation factor 2 alpha). They may as a result be important in mitigating the severity of COVID-19, acting through the endoplasmic reticulum stress or ACE-Angiotensin-II-AT(1)R axis (AT(1)R) pathway. Many Nrf2-interacting nutrients are also interacting with TRPA1 and/or TRPV1. Interestingly, geographical areas with very low COVID-19 mortality are those with the lowest prevalence of obesity (Sub-Saharan Africa and Asia). It is tempting to propose that Nrf2-interacting foods and nutrients can re-balance insulin resistance and have a significant effect on COVID-19 severity. It is therefore possible that the intake of these foods may restore an optimal natural balance for the Nrf2 pathway and may be of interest in the mitigation of COVID-19 severity

Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants

Summary Background Comparable global data on health and nutrition of school-aged children and adolescents are scarce. We aimed to estimate age trajectories and time trends in mean height and mean body-mass index (BMI), which measures weight gain beyond what is expected from height gain, for school-aged children and adolescents. Methods For this pooled analysis, we used a database of cardiometabolic risk factors collated by the Non-Communicable Disease Risk Factor Collaboration. We applied a Bayesian hierarchical model to estimate trends from 1985 to 2019 in mean height and mean BMI in 1-year age groups for ages 5–19 years. The model allowed for non-linear changes over time in mean height and mean BMI and for non-linear changes with age of children and adolescents, including periods of rapid growth during adolescence. Findings We pooled data from 2181 population-based studies, with measurements of height and weight in 65 million participants in 200 countries and territories. In 2019, we estimated a difference of 20 cm or higher in mean height of 19-year-old adolescents between countries with the tallest populations (the Netherlands, Montenegro, Estonia, and Bosnia and Herzegovina for boys; and the Netherlands, Montenegro, Denmark, and Iceland for girls) and those with the shortest populations (Timor-Leste, Laos, Solomon Islands, and Papua New Guinea for boys; and Guatemala, Bangladesh, Nepal, and Timor-Leste for girls). In the same year, the difference between the highest mean BMI (in Pacific island countries, Kuwait, Bahrain, The Bahamas, Chile, the USA, and New Zealand for both boys and girls and in South Africa for girls) and lowest mean BMI (in India, Bangladesh, Timor-Leste, Ethiopia, and Chad for boys and girls; and in Japan and Romania for girls) was approximately 9–10 kg/m2. In some countries, children aged 5 years started with healthier height or BMI than the global median and, in some cases, as healthy as the best performing countries, but they became progressively less healthy compared with their comparators as they grew older by not growing as tall (eg, boys in Austria and Barbados, and girls in Belgium and Puerto Rico) or gaining too much weight for their height (eg, girls and boys in Kuwait, Bahrain, Fiji, Jamaica, and Mexico; and girls in South Africa and New Zealand). In other countries, growing children overtook the height of their comparators (eg, Latvia, Czech Republic, Morocco, and Iran) or curbed their weight gain (eg, Italy, France, and Croatia) in late childhood and adolescence. When changes in both height and BMI were considered, girls in South Korea, Vietnam, Saudi Arabia, Turkey, and some central Asian countries (eg, Armenia and Azerbaijan), and boys in central and western Europe (eg, Portugal, Denmark, Poland, and Montenegro) had the healthiest changes in anthropometric status over the past 3·5 decades because, compared with children and adolescents in other countries, they had a much larger gain in height than they did in BMI. The unhealthiest changes—gaining too little height, too much weight for their height compared with children in other countries, or both—occurred in many countries in sub-Saharan Africa, New Zealand, and the USA for boys and girls; in Malaysia and some Pacific island nations for boys; and in Mexico for girls. Interpretation The height and BMI trajectories over age and time of school-aged children and adolescents are highly variable across countries, which indicates heterogeneous nutritional quality and lifelong health advantages and risks

Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world

Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection

Robust estimation of bacterial cell count from optical density

Optical density (OD) is widely used to estimate the density of cells in liquid culture, but cannot be compared between instruments without a standardized calibration protocol and is challenging to relate to actual cell count. We address this with an interlaboratory study comparing three simple, low-cost, and highly accessible OD calibration protocols across 244 laboratories, applied to eight strains of constitutive GFP-expressing E. coli. Based on our results, we recommend calibrating OD to estimated cell count using serial dilution of silica microspheres, which produces highly precise calibration (95.5% of residuals &lt;1.2-fold), is easily assessed for quality control, also assesses instrument effective linear range, and can be combined with fluorescence calibration to obtain units of Molecules of Equivalent Fluorescein (MEFL) per cell, allowing direct comparison and data fusion with flow cytometry measurements: in our study, fluorescence per cell measurements showed only a 1.07-fold mean difference between plate reader and flow cytometry data